Exane Derivatives’s Lear LEA Stock Holding History
Bought
Maintained
Sold
Other funds holding LEA
Exane Derivatives's LEA Position: Q1 2021 in Review
Exane Derivatives sold out of Lear (LEA) in Q1 2021, closing a stake of 529 shares — an estimated $84.1K sold.
Exane Derivatives first reported a position in LEA in Q1 2016 and held it in 20 quarters. The position peaked at $14.1M in Q1 2016. 431 funds tracked by Wall St. Rank hold LEA as of Q1 2021.
- Exane Derivatives reported no remaining Lear position as of Q1 2021 after selling out during the quarter.
- Exane Derivatives sold 529 Lear shares in Q1 2021, an estimated $84.1K.
- Exane Derivatives first reported a position in Lear in Q1 2016 and held it in 20 quarters.
- Exane Derivatives's Lear position peaked at $14.1M in Q1 2016.
- 431 funds tracked by Wall St. Rank held Lear as of Q1 2021.
Based on Exane Derivatives's 13F filing for Q1 2021, filed 30 Apr 2021.